BG105840A - Heterocyclic benzenesulphonamide compounds as bradykinine antagonists - Google Patents
Heterocyclic benzenesulphonamide compounds as bradykinine antagonistsInfo
- Publication number
- BG105840A BG105840A BG105840A BG10584001A BG105840A BG 105840 A BG105840 A BG 105840A BG 105840 A BG105840 A BG 105840A BG 10584001 A BG10584001 A BG 10584001A BG 105840 A BG105840 A BG 105840A
- Authority
- BG
- Bulgaria
- Prior art keywords
- compounds
- heterocyclic
- bradykinine
- antagonists
- apices
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9902412A FR2790260B1 (fr) | 1999-02-26 | 1999-02-26 | Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique |
| PCT/FR2000/000396 WO2000050418A1 (fr) | 1999-02-26 | 2000-02-17 | Composes heterocycliques de benzenesulfonamide en tant qu'antagonistes de la bradykinine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG105840A true BG105840A (en) | 2002-04-30 |
Family
ID=9542576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG105840A BG105840A (en) | 1999-02-26 | 2001-08-24 | Heterocyclic benzenesulphonamide compounds as bradykinine antagonists |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6479515B1 (es) |
| EP (1) | EP1155013B1 (es) |
| JP (1) | JP4564666B2 (es) |
| KR (1) | KR20010102057A (es) |
| CN (1) | CN1340050A (es) |
| AR (1) | AR022754A1 (es) |
| AT (1) | ATE245640T1 (es) |
| AU (1) | AU2809600A (es) |
| BG (1) | BG105840A (es) |
| BR (1) | BR0008221A (es) |
| CA (1) | CA2371853C (es) |
| CZ (1) | CZ303169B6 (es) |
| DE (1) | DE60004017T2 (es) |
| DK (1) | DK1155013T3 (es) |
| EE (1) | EE04839B1 (es) |
| ES (1) | ES2202059T3 (es) |
| FR (1) | FR2790260B1 (es) |
| HK (1) | HK1041267A1 (es) |
| HR (1) | HRP20010619A2 (es) |
| HU (1) | HUP0200281A3 (es) |
| ID (1) | ID29914A (es) |
| IL (1) | IL144720A0 (es) |
| MX (1) | MXPA01008672A (es) |
| NO (1) | NO20014048L (es) |
| NZ (1) | NZ513732A (es) |
| PL (1) | PL199209B1 (es) |
| PT (1) | PT1155013E (es) |
| SK (1) | SK286710B6 (es) |
| TN (1) | TNSN00031A1 (es) |
| WO (1) | WO2000050418A1 (es) |
| ZA (1) | ZA200106250B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6809093B2 (en) * | 2000-10-17 | 2004-10-26 | H. Lee Moffitt Cancer & Research Institute, Inc. | 2-substituted heterocyclic compounds |
| TW200303742A (en) * | 2001-11-21 | 2003-09-16 | Novartis Ag | Organic compounds |
| CA2509881A1 (en) * | 2002-12-19 | 2004-07-08 | Elan Pharmaceuticals, Inc. | Substituted n-phenyl sulfonamide bradykinin antagonists |
| EP1633743A1 (en) * | 2003-04-10 | 2006-03-15 | Amgen, Inc. | Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| JP2006526015A (ja) | 2003-05-02 | 2006-11-16 | エラン ファーマシューティカルズ，インコーポレイテッド | 炎症疾患治療のためのブラジキニンｂ１受容体アンタゴニストとしての４−ブロモ−５−（２−クロロ−ベンゾイルアミノ）−１ｈ−ピラゾール−３−カルボン酸アミド誘導体および関連化合物 |
| EP1633349A1 (en) * | 2003-05-02 | 2006-03-15 | Elan Pharmaceuticals, Inc. | 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| CA2524318A1 (en) * | 2003-05-02 | 2004-11-18 | Elan Pharmaceuticals, Inc. | 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases |
| ES2436020T3 (es) * | 2006-09-29 | 2013-12-26 | Grünenthal GmbH | Derivados de sulfonamida sustituidos |
| TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽ｂ２受體調節劑 |
| AR073304A1 (es) * | 2008-09-22 | 2010-10-28 | Jerini Ag | Moduladores del receptor de bradiquinina b2 de molecula pequena |
| CN104822267B (zh) * | 2012-02-29 | 2018-01-23 | 巴鲁克·S·布伦博格研究所 | 乙型肝炎病毒共价闭合环状dna形成的抑制剂及其使用方法 |
| EP3713928B1 (en) | 2017-11-24 | 2022-01-12 | Pharvaris Netherlands B.V. | Novel bradykinin b2 receptor antagonists |
| AR118982A1 (es) * | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| AR118983A1 (es) | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| WO2023180577A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Therapeutic uses of bradykinin b2-receptor antagonists |
| WO2023180575A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Solid composition comprising solubilised bradykinin b2-receptor antagonists |
| TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3617183A1 (de) | 1985-11-16 | 1987-05-27 | Bayer Ag | Substituierte benzylether |
| US5202336A (en) | 1986-09-24 | 1993-04-13 | Bayer Aktiengesellschaft | Antiflammatory quinolin methoxy phenylsulphonamides |
| DE3632329A1 (de) | 1986-09-24 | 1988-03-31 | Bayer Ag | Substituierte phenylsulfonamide |
| US5610140A (en) | 1991-04-01 | 1997-03-11 | Cortech, Inc. | Bradykinin receptor antagonists with neurokinin receptor blocking activity |
| WO1992017201A1 (en) | 1991-04-01 | 1992-10-15 | Cortech, Inc. | Bradykinin antagonists |
| TW258739B (es) | 1992-04-04 | 1995-10-01 | Hoechst Ag | |
| US5610142A (en) | 1992-10-08 | 1997-03-11 | Scios Inc. | Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids |
| AU686115B2 (en) | 1992-11-02 | 1998-02-05 | Fujisawa Pharmaceutical Co., Ltd. | Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation |
| US5510380A (en) | 1993-02-19 | 1996-04-23 | Sterling Winthrop, Inc. | Nonpeptide bradykinin antagonists |
| AU680870B2 (en) | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
| ES2218554T3 (es) | 1994-10-27 | 2004-11-16 | Fujisawa Pharmaceutical Co., Ltd. | Piridopirimidonas, quinolinas y n-heterociclos condensados que son antagonistas de bradiquinina. |
| JPH0940662A (ja) | 1995-05-24 | 1997-02-10 | Kyowa Hakko Kogyo Co Ltd | 三環式化合物 |
| FR2735128B1 (fr) | 1995-06-07 | 1997-07-25 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique. |
| FR2737892B1 (fr) | 1995-08-17 | 1997-10-24 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique |
| US5849863A (en) | 1995-09-08 | 1998-12-15 | University Of Colorado | Cytolytic bradykinin antagonists |
| US5834431A (en) | 1995-09-08 | 1998-11-10 | Cortech, Inc. | Des-Arg9 -BK antagonists |
| GB9519077D0 (en) | 1995-09-18 | 1995-11-15 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
| FR2743073B1 (fr) * | 1995-12-29 | 1998-02-20 | Fournier Ind & Sante | Nouveaux composes de 1-benzenesulfonylpyrrolidine, procede de preparation et utilisation en therapeutique |
| AUPN952696A0 (en) | 1996-04-29 | 1996-05-23 | Fujisawa Pharmaceutical Co., Ltd. | New heterocyclic compounds |
| FR2751650B1 (fr) * | 1996-07-24 | 1998-10-09 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
| FR2756562B1 (fr) * | 1996-12-04 | 1999-01-08 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
| FR2765222B1 (fr) | 1997-06-27 | 1999-12-31 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
-
1999
- 1999-02-26 FR FR9902412A patent/FR2790260B1/fr not_active Expired - Fee Related
-
2000
- 2000-02-17 DE DE60004017T patent/DE60004017T2/de not_active Expired - Lifetime
- 2000-02-17 WO PCT/FR2000/000396 patent/WO2000050418A1/fr not_active Application Discontinuation
- 2000-02-17 CN CN00803551A patent/CN1340050A/zh active Pending
- 2000-02-17 ES ES00906414T patent/ES2202059T3/es not_active Expired - Lifetime
- 2000-02-17 SK SK1192-2001A patent/SK286710B6/sk not_active IP Right Cessation
- 2000-02-17 CA CA002371853A patent/CA2371853C/en not_active Expired - Fee Related
- 2000-02-17 IL IL14472000A patent/IL144720A0/xx unknown
- 2000-02-17 DK DK00906414T patent/DK1155013T3/da active
- 2000-02-17 KR KR1020017010157A patent/KR20010102057A/ko not_active Application Discontinuation
- 2000-02-17 AU AU28096/00A patent/AU2809600A/en not_active Abandoned
- 2000-02-17 CZ CZ20013067A patent/CZ303169B6/cs not_active IP Right Cessation
- 2000-02-17 NZ NZ513732A patent/NZ513732A/xx not_active Application Discontinuation
- 2000-02-17 PL PL350234A patent/PL199209B1/pl unknown
- 2000-02-17 HU HU0200281A patent/HUP0200281A3/hu unknown
- 2000-02-17 US US09/889,965 patent/US6479515B1/en not_active Expired - Fee Related
- 2000-02-17 MX MXPA01008672A patent/MXPA01008672A/es unknown
- 2000-02-17 BR BR0008221-0A patent/BR0008221A/pt not_active IP Right Cessation
- 2000-02-17 EE EEP200100444A patent/EE04839B1/xx not_active IP Right Cessation
- 2000-02-17 ID IDW00200101795A patent/ID29914A/id unknown
- 2000-02-17 JP JP2000600999A patent/JP4564666B2/ja not_active Expired - Fee Related
- 2000-02-17 PT PT00906414T patent/PT1155013E/pt unknown
- 2000-02-17 AT AT00906414T patent/ATE245640T1/de active
- 2000-02-17 EP EP00906414A patent/EP1155013B1/fr not_active Expired - Lifetime
- 2000-02-18 TN TNTNSN00031A patent/TNSN00031A1/fr unknown
- 2000-02-25 AR ARP000100812A patent/AR022754A1/es unknown
-
2001
- 2001-07-30 ZA ZA200106250A patent/ZA200106250B/en unknown
- 2001-08-20 NO NO20014048A patent/NO20014048L/no not_active Application Discontinuation
- 2001-08-24 HR HR20010619A patent/HRP20010619A2/hr not_active Application Discontinuation
- 2001-08-24 BG BG105840A patent/BG105840A/xx unknown
-
2002
- 2002-04-23 HK HK02103040.2A patent/HK1041267A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG105840A (en) | Heterocyclic benzenesulphonamide compounds as bradykinine antagonists | |
| TR200000014T2 (tr) | Yeni ikameli imidazol bileşimleri. | |
| MX9605128A (es) | Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos. | |
| DE68907921D1 (de) | Substituierte pyrrol-, pyrazol- und triazol-angiotensin ii-antagonisten. | |
| EE200200192A (et) | 5-(2-asendatud-5-heterotsüklüülsulfonüülpürid-3-üül)dihüdropürasolo[4,3-d]pürimidii n-7-oonid kui fosfodiesteraasi inhibiitorid | |
| MX9700696A (es) | Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos. | |
| MX9700430A (es) | El uso de compuestos heterociclicos. | |
| BR9608591A (pt) | Compostos de imidazol | |
| EP1242085A4 (en) | BENZIMIDAZOLE COMPOUNDS WITH A NOCICEPTIN RECEPTOR AFFINITY | |
| BR9706973A (pt) | Novos compostos de imidazol substituídos | |
| AU6520098A (en) | Azole compounds, their production and their use | |
| PL341239A1 (en) | Dihydrobenzofuranes | |
| MY103241A (en) | Imidazole and 1,2,4 triazole derivatives | |
| CA2331187A1 (en) | Water soluble azoles as broad-spectrum antifungals | |
| HK1041264A1 (en) | Imidazole compounds and their use as adenosine deaminase inhibitors | |
| ES2143224T3 (es) | Derivados naftamida de 3-beta-amino azabiciclo octano o nonano, como agentes antipsicoticos. | |
| NZ504124A (en) | Phenyl-alkyl-imidazoles and use in treating inflammatory disease | |
| DE60010914D1 (de) | Wasserfreie salze | |
| TR200002610A2 (tr) | Antifungal faaliyeti olan triazol türevleri | |
| SI0937075T1 (en) | New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors. | |
| ES2133376T3 (es) | Derivados de imidazol y su uso como agentes agroquimicos. | |
| PL343848A1 (en) | Novel benzimidazoles and benzoxazoles | |
| UY24784A1 (es) | Nuevos compuestos de imidazol sustituidos | |
| MX9800046A (es) | Agentes antifungicos de triazol, uso de los mismos, composiciones que los contienen y procediminto para preparar los mismos. |